We have Vaccine for COVID-19! What to Recommend for Pregnant Women?
Silvana Maria Quintana
Abstract
On January 17, 2021, two vaccines were approved by ANVISA for emergency use to help combat COVID-19: Coronavac and Covishield/Oxford. The first vaccine is composed of inactivated (killed) viruses, was produced by the Chinese company Sinovac and in Brazil, will be produced by the Butantã Institute (São Paulo). The second is an adenovirus non-replicating viral vector vaccine and was produced by the pharmaceutical company Serum Institute of India in partnership with AstraZeneca/Oxford University. In Brazil, it will be produced by the Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)General partnershipSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyFamily medicineMedicinePandemicLibrary sciencePolitical scienceInfectious disease (medical specialty)Internal medicineOutbreakLawComputer scienceDiseaseCOVID-19 Impact on ReproductionGlobal Maternal and Child HealthPregnancy and Medication Impact